Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preservative-Free Tafluprost vs Timolol in Glaucoma/OHT in India
NCT01254604Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2011
- Primary completion
- May 2013
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of tafluprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Merck & Co.. Started Dec 2011; status: completed.
02
Drugs
tafluprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT01254604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01254604.